Related Experiment Video
Updated: Mar 13, 2026
07:38
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
890
STIP Regulates ERK1/2 Signaling Pathway Involved in Interaction with PP1γ in Lymphoblastic Leukemia
1Department of Hematology, Xiangya Hospital, Central South University, Changsha 410008, China. zhaoxl9198@163.com.
Current Molecular Medicine
|October 21, 2016
Summary
Sip1/Tuftelin Interacting Protein (STIP) is highly expressed in lymphoblastic leukemia, where it promotes cancer cell growth by activating ERK1/2 signaling. STIP interacts with protein phosphatase 1 gamma, suggesting it as a potential therapeutic target for leukemia.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Sip1/Tuftelin Interacting Protein (STIP) is a conserved protein with essential biological roles.
- The specific function of STIP in leukemia pathogenesis has not been previously elucidated.
Purpose of the Study:
- To investigate the expression and function of STIP in lymphoblastic leukemia.
- To explore the molecular mechanisms by which STIP influences leukemia cell behavior.
Main Methods:
- Analysis of STIP expression in clinical lymphoblastic leukemia samples and cell lines.
- Functional studies using siRNA-mediated STIP knockdown in ARH-77 cells.
- Assays included immunofluorescence, cell counting, cell cycle analysis, qRT-PCR, western blotting, and immunoprecipitation.
Main Results:
- STIP expression is significantly elevated in lymphoblastic leukemia samples and cells compared to normal controls.
- STIP knockdown in ARH-77 cells induced S phase arrest, reduced proliferation, and suppressed AKT/ERK1/2 signaling.
- STIP interacts with protein phosphatase 1 gamma (PP1γ), and this interaction may lead to hyper-activation of ERK1/2 signaling.
Conclusions:
- STIP is overexpressed in lymphoblastic leukemia and plays a role in regulating cell proliferation and signaling pathways.
- The interaction between STIP and PP1γ suggests a novel mechanism for ERK1/2 pathway dysregulation in leukemia.
- STIP represents a potential diagnostic marker and therapeutic target for lymphoblastic leukemia.
Related Concept Videos
01:19Interactions Between Signaling Pathways
7.7K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.7K
01:20The JAK-STAT Signaling Pathway
13.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.6K
01:22PI3K/mTOR/AKT Signaling Pathway
6.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.1K
01:07MAPK Signaling Cascades
9.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.0K
02:23Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
02:38Mitogens and the Cell Cycle
8.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K